VientianeTimes-Jan 4 

State Enterprise Pharmaceutical Factory No. 3 in Vientiane is manufacturing a revolutionary new drug named Molacovir for use in the early stages of Covid-19. The drug is administered orally and under Lao copyright is known as Molacovir.  The new drug formula was first used in the treatment of influenza and was developed by scientists at Emory University in the United States. The US Food and Drug Administration (FDA) has approved molnupiravir for use in the early treatment of Covid-19 patients, raising confidence in the future reduction of the high mortality rate from the virus. The manufacture of Molacovir in Laos and the pilot program will be monitored by the World Health Organisation. A senior official at the factory, who asked not to be named, told Vientiane Times on Friday that the factory began making the pills in December and has so far manufactured enough to treat about 1,000 Covid-19 patients.
The main benefit of Molacovir is that it can be administered orally in pill form instead of needing to be injected. Forty capsules are required for each Covid patient. Read more at: https://www.vientianetimes.org.la/freeContent/FreeConten_Lao_factory_01.php